Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-29 @ 11:02 PM
Study NCT ID:
NCT00626561
Status:
TERMINATED
Last Update Posted:
2014-07-07
First Post:
2008-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-20
First Submit QC Date:
None
Study First Post Date:
2008-02-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-05
Results First Submit QC Date:
None
Results First Post Date:
2014-07-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-05
Last Update Post Date:
2014-07-07
Last Update Post Date Type:
ESTIMATED